Sort
11,323 grants matching “glioblastoma”
Efficacy of Distant Healing in Glioblastoma Treatment
$203,993California Pacific Med Ctr Res Institute · R01 · FY2001 · AT
Phosphoinositide Regulation of Focal Adhesion Structure
$203,826Oregon State University · R01 · FY2005 · GM
A novel sustained-release immunotoxin for treatment of glioblastoma multiforme
$203,646Ashutosh Chilkoti · Duke University · R21 · FY2019 · CA
3D-Microtumor_GBM Xenoline Proband Modeling of Kinome-Directed Therapy
$203,585Christopher D Willey · University Of Alabama At Birmingham · R21 · FY2014 · CA
Photodynamic Priming for Bidirectional Modulation of Drug Transport Across the Blood-Brain Tumor Barrier
$203,530Huang Chiao Huang · Univ Of Maryland, College Park · R21 · FY2020 · EB
Characterization of CD44 in brain tumor stem cells
$203,280Ichiro Nakano · University Of California Los Angeles · R21 · FY2009 · CA
TAS::75 0849::TAS DEVELOPMENT OF ROS KINASE INHIBITORS - PHASE I SBIR TOPIC 255
$203,208Dorre A Grueneberg · Augusta Pharmaceuticals, Inc. · N43 · FY2010 · CA
REGULATION OF APOPTOSIS IN CANCER CELLS
$202,989Albert M Magro · Marshall University · P20 · FY2008 · RR
Multifunctional, GBM-Activatable Nanocarriers For Image-Guided Photochemotherapy
$202,977Huang Chiao Huang · Univ Of Maryland, College Park · R00 · FY2020 · CA
Developing an image-guided therapeutic strategy to effectively target metabolic reprogramming in glioblastoma
$202,950Inan Olmez · Pennsylvania State Univ Hershey Med Ctr · R21 · FY2023 · NS
Mitotic Regulation by the ERRbeta2 Splice Variant
$202,928Rebecca B Riggins · Georgetown University · R21 · FY2015 · CA
Targeting and Delivering CAR-Ts in Glioblastoma
$202,928Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R21 · FY2019 · CA
Efficacy of Distant Healing in Glioblastoma Treatment
$202,596California Pacific Med Ctr Res Institute · R01 · FY2000 · AT
Targeting cell polarity to disrupt the interaction of glioblastomas with the neural environment
$202,500Mariano Sebastian Viapiano · Upstate Medical University · R21 · FY2020 · NS
Targeting the tumor matrix as immune-boosting strategy for malignant gliomas
$202,500Mariano Sebastian Viapiano · Upstate Medical University · R21 · FY2020 · NS
An experimental system designed to identify human cytomegalovirus-induced alterations in tumor cells and test their dependence on continued viral gene expression
$202,500Thomas E Shenk · Princeton University · R21 · FY2019 · AI
Elucidating the Role of the Gut and Tumor Microbiome in Malignant Glioma
$202,500Sherise Desiree Ferguson · University Of Tx Md Anderson Can Ctr · R21 · FY2024 · NS
The Role of Sphingosine Kinase in Glioblastoma Stem Cells
$202,500James R Van Brocklyn · Ohio State University · R21 · FY2008 · CA
CCSG Supplement: Early-stage Surgeon Scientist Program (ESSP) - Chibawanye Ene
$202,500Giulio Francesco Draetta · University Of Tx Md Anderson Can Ctr · P30 · FY2023 · CA
GEMZAR--MECHANISMS OF CYTOTOXICITY &RADIOSENSITIZATION
$202,459University Of Michigan At Ann Arbor · R01 · FY2000 · CA
IGF1R-targeted oncolytic herpes simplex viral therapy for Glioblastoma
$202,429Ji Young Yoo · University Of Texas Hlth Sci Ctr Houston · R21 · FY2023 · NS
IGF1R-targeted oncolytic herpes simplex viral therapy for Glioblastoma
$202,429Ji Young Yoo · University Of Texas Hlth Sci Ctr Houston · R21 · FY2022 · NS
Selectively Targeting a PI3K subunit to overcome temozolomide resistance and treat recurrent glioblastoma
$202,343Zhi Sheng · Virginia Polytechnic Inst And St Univ · R21 · FY2018 · CA
Targeted Delivery of a Novel Synthetic Curcumin Analog, EF24 to Glioblastoma and
$202,275Mamoru None Shoji · Emory University · R21 · FY2012 · CA
Phase I Vaccine Study using Brain Tumor Initiating Cells in WHO Grade II Gliomas
$202,051Hideho Okada · University Of California, San Francisco · R21 · FY2015 · CA